e-learning
resources
Courses
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inflammatory markers
M. Pijnenburg (Rotterdam, Netherlands)
Source:
ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Number:
1
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pijnenburg (Rotterdam, Netherlands). Inflammatory markers. ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Congenital malformations
Bronchopulmonary dysplasia and chronic lung disease of prematurity
Workshops - Endoscopy
Related content which might interest you:
Inflammatory phenotypes of COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
Inflammatory markers in COPD patients with and without cachexia
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Inflammatory markers in relation to cachexia in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
Inflammatory myofibroblastic tumour
Source: Eur Respir J 2010; 35: 1422-1423
Year: 2010
Inflammatory molecular endotypes in bronchiectasis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Inflammatory myofibroblastic tumour of the central airways: treatment and molecular analysis
Source: ERJ Open Res, 7 (1) 00151-2020; 10.1183/23120541.00151-2020
Year: 2021
Inflammatory bowel diseases and the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 55s
Year: 2006
Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Biomarkers of eosinophilic inflammation
Source: Eur Respir Monogr 2022; 95: 37-50
Year: 2022
Inflammatory markers and lipid profile in COPD patients over nine years
Source: International Congress 2017 – COPD biomarkers
Year: 2017
The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Phenotyping of the inflammatory sarcoid response
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Leptin, inflammatory biomarkers and body composition in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Multi-analyte profiling of inflammatory markers in COPD sputum
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Inflammation markers: Dependence from severity of AECOPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept